comparemela.com
Home
Live Updates
SAB Biotherapeutics : Reports Full Year 2023 Operating and Financial Results March 29, 2024 - Form 8-K -March 29, 2024 at 09:38 am EDT : comparemela.com
SAB Biotherapeutics : Reports Full Year 2023 Operating and Financial Results March 29, 2024 - Form 8-K -March 29, 2024 at 09:38 am EDT
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
March 29, 2024
SAB-142 Phase 1 trial on track for data release during 2024
...
Related Keywords
New York
,
United States
,
Michaelg King Jr
,
Andrew Moin
,
Erick Lucera
,
Samuelj Reich
,
Katie Ellias
,
Rd Fund
,
Exchange Commission
,
Twitter
,
Linkedin
,
Biotherapeutics Inc
,
Nasdaq
,
Young
,
Reports Full Year
,
Financial Results
,
Recent Corporate Developments
,
Chief Financial
,
Sessa Capital
,
New York City Chapter
,
Managing Partner
,
Veralox Therapeutics
,
Chief Financial Officer
,
Annual Needham Virtual Conference
,
Private Securities Litigation Reform Act
,
Markets
,
comparemela.com © 2020. All Rights Reserved.